Key Metrics of Myriad Genetics
Revenue$753M▲ 11.0% YoYFY 2023
Operating income−$257M▼ 83.1% YoY
Net profit−$263M▼ 134.8% YoY
Shareholders' equity$783M
Market cap$638MMYGN · $6.67
Competitors10identified
About Myriad Genetics
Part of Myriad Genetics.
Sectors
Company details
- Website
- myriad.com
- Founded
- 1995
- Listed
- Nasdaq: MYGN (since 1995)
Operational Areas of Myriad Genetics
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameMyriad Genetics Inc.
TickerMYGN
ExchangeNasdaq
CountryUnited States
SEC CIK0000899923
Listed since1995
IndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://myriad.com
US market & SEC filings
MYGN · Nasdaq · SEC CIK 0000899923
Last price · 31 Oct 2026
$6.67
+0.60%
Market cap$638M
P/E—On FY 2023 diluted EPS
Volume1,470,889
SectorHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances
Country · IPOUnited StatesListed 1995
MYGN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeSalt Lake City
GSTIN—
Email—
Websitehttps://myriad.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Myriad Genetics
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of Myriad Genetics
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.